CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-28 | Simpson Curran SVP, Product Development & CTO | Sale | −18,000 | $50.00 | $900K | 39,500 |
| 2019-05-28 | Simpson Curran SVP, Product Development & CTO | Exercise or conversion · Stock Option (Right to Buy) | −18,000 | 25,219 | ||
| 2019-05-20 | Mills Kenneth T. President and CEO | Exercise or conversion | +15,000 | $0.85 | $13K | 261,000 |
| 2019-05-20 | Mills Kenneth T. President and CEO | Sale | −4,141 | $42.08 | $174K | 256,859 |
| 2019-05-20 | Mills Kenneth T. President and CEO | Sale | −10,559 | $43.32 | $457K | 246,300 |
| 2019-05-20 | Mills Kenneth T. President and CEO | Sale | −300 | $43.99 | $13K | 246,000 |
| 2019-05-20 | Mills Kenneth T. President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −15,000 | 129,670 | ||
| 2019-04-22 | Mills Kenneth T. President and CEO | Exercise or conversion | +15,000 | $0.85 | $13K | 261,000 |
| 2019-04-22 | Mills Kenneth T. President and CEO | Sale | −3,401 | $49.29 | $168K | 257,599 |
| 2019-04-22 | Mills Kenneth T. President and CEO | Sale | −6,929 | $50.31 | $349K | 250,670 |
| 2019-04-22 | Mills Kenneth T. President and CEO | Sale | −3,270 | $51.07 | $167K | 247,400 |
| 2019-04-22 | Mills Kenneth T. President and CEO | Sale | −1,300 | $52.33 | $68K | 246,100 |
| 2019-04-22 | Mills Kenneth T. President and CEO | Sale | −100 | $53.05 | $5K | 246,000 |
| 2019-04-22 | Mills Kenneth T. President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −15,000 | 144,670 | ||
| 2019-04-18 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion | +3,541 | $12.10 | $43K | 6,547 |
| 2019-04-18 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion | +1,459 | $19.50 | $28K | 8,006 |
| 2019-04-18 | Christmas Patrick J. SVP, General Counsel | Sale | −2,900 | $52.55 | $152K | 5,106 |
| 2019-04-18 | Christmas Patrick J. SVP, General Counsel | Sale | −1,115 | $53.67 | $60K | 3,991 |
| 2019-04-18 | Christmas Patrick J. SVP, General Counsel | Sale | −885 | $54.66 | $48K | 3,106 |
| 2019-04-18 | Christmas Patrick J. SVP, General Counsel | Sale | −100 | $55.50 | $6K | 3,006 |
Page 28 of 43 · 852 trades